Table 1.
Comparison of Mongolian Patients with Chronic Hepatitis B mono-infection Versus Co-infection with Hepatitis D Virus.
| HBV mono-infection (N=35, 66%) | HBV-HDV co-infection (N=18, 34%) | p-value | |
|---|---|---|---|
| Age (years) | 34 ± 10 | 41 ± 10 | 0.025 |
| Sex (male) | 57% | 61% | 1 |
| BMI (kg/m2) | 26.5 ± 5.6 | 24.9 ± 5.5 | 0.63 |
| Years in US (years) | 6.1 ± 4.5 | 6.2 ± 6.0 | 0.959 |
| Hepatitis B e Antigen | 9% | 11% | 1 |
| AST (U/L) | 25 (22–30) | 57 (40–113) | <0.001 |
| ALT (U/L) | 29 (18–37) | 71 (44–91) | <0.001 |
| Albumin (g/dL) | 4.9 (4.6–5.1) | 4.8 (4.4–4.8) | 0.075 |
| Total bilirubin (mg/dL) | 0.5 (0.4–0.7) | 0.7 (0.6–1.0) | 0.007 |
| Platelet count (× 109 per L) | 237 ± 86 | 173 ± 44 | 0.001 |
| AFP (ng/mL) | 3 (2–7) | 6 (3–10) | 0.126 |
| HBV DNA (IU/mL) | 212(24–4653) | 0 (0–131) | 0.011 |
| Liver stiffness (kPa) | 6.1 ± 2.4 | 11.1 ± 5.6 | 0.007 |
| FibroScan Fibrosis score F3-F4 | 13% | 57% | 0.013 |
| FIB-4 Score | 0.69 (0.57–0.93) | 1.68 (1.36–2.79) | <0.001 |
Values provided as mean ± standard deviation, median (interquartile range), or column percentage.
Comparisons between groups were made by student’s t-test, Mann-Whitney U test, or chi-square analysis, as appropriate.